The case looked like a slam-dunk. A drug company allegedly cornered the market on a medicine — not just any medicine, but one used to treat premature babies with life-threatening heart defects — then raised prices 1,300%. How did the FTC blow it?
September 27, 2010 at 12:00 AM
1 minute read
The case looked like a slam-dunk for the Federal Trade Commission.
A drug company allegedly cornered the market on a medicine — not just any medicine, but one used to treat premature babies with life-threatening heart defects — then raised prices 1,300%.
Presented by BigVoodoo
The National Law Journal Elite Trial Lawyers recognizes U.S.-based law firms performing exemplary work on behalf of plaintiffs.
The National Law Journal honors attorneys & judges who've made a remarkable difference in the legal profession in the D.C. area.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Epstein Becker & Green is seeking an associate to joins its Commercial Litigation practice in our Columbus or Cincinnati offices. Ca...
Job Opportunity: Location: Prestigious Florida Law Firm seeks to hire a Business attorney with at least 5 years of experience for their Ft. ...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
Breaking news and trends for law firm and legal departments about the evolving federal regulations in a volatile political climate.
